Small Molecules

14 Apr 2007 MediGene Initiates Clinical Phase II Trial of EndoTAG(TM)-1 for the Treatment of Hormone Receptor Negative Breast Cancer
13 Apr 2007 Hybrigenics' Inecalcitol Shows High Level of Tolerance For further
13 Apr 2007 Cytokinetics Announces Initiation of Phase II Clinical Trials Program for CK-1827452
13 Apr 2007 GSK initiates repeat dosing study of its novel oral platelet growth factor, eltrombopag, in ITP
13 Apr 2007 Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
13 Apr 2007 Array BioPharma Achieves Milestone for Dosing MEK Inhibitor, ARRY-704, in Phase 1 Clinical Trial
13 Apr 2007 GSK announces FDA approval of Altabax(TM)(retapamulin ointment), 1%
12 Apr 2007 Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
12 Apr 2007 New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders
12 Apr 2007 Senetek Initiates Clinical Trials of Pyratine 6 for Acne Rosacea Comparison of Pyratine 6 and Kinetin Clinicals Shows Dramatic Advancements
12 Apr 2007 Xanthus Acquires from Johns Hopkins University Exclusive License to Patent Estate Covering FLT3 Pathway as a Target for Treating Autoimmune Diseases
12 Apr 2007 Pharmaxis Begins Phase III Cystic Fibrosis Trial
12 Apr 2007 MacroChem Completes Patient Enrollment for Phase II Trial of Econail(TM) for Treatment of Onychomycosis
12 Apr 2007 Repligen Licenses Potential Treatment for Friedreich's Ataxia from The Scripps Research Institute
12 Apr 2007 Obecure Completes Patient Enrollment for Phase II Obesity Trial
12 Apr 2007 Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
12 Apr 2007 Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic
11 Apr 2007 Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
11 Apr 2007 Coley Pharmaceutical Group Announces Completion of Patient Enrollment in Pfizer's Two Pivotal Phase III NSCLC Clinical Trials
11 Apr 2007 Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
11 Apr 2007 NeuroSearch's license partner Astellas initiates clinical Phase Ib study with ACR16 in patients with schizophrenia
11 Apr 2007 Novalar Submits New Drug Application for Anesthetic Reversal Agent NV-101
11 Apr 2007 Studies Intended to Broaden Market Potential for Neuropathic Pain Uses
11 Apr 2007 Ambit Biosciences Begins Dosing Patients in Phase I Clinical Trial of Lead Kinase Inhibitor AC220
11 Apr 2007 CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up